Neonatal Exposure to Citalopram Selectively Alters the Expression of the Serotonin Transporter in the Hippocampus: Dose‐Dependent Effects
Open Access
- 9 September 2010
- journal article
- research article
- Published by Wiley in The Anatomical Record
- Vol. 293 (11), 1920-1932
- https://doi.org/10.1002/ar.21245
Abstract
Infants born to mothers taking selective serotonin reuptake inhibitors (SSRIs) late in pregnancy have been reported to exhibit signs of antidepressant withdrawal. Such evidence suggests that these drugs access the fetal brain in utero at biologically significant levels. Recent studies in rodents have revealed that early exposure to antidepressants can lead to long lasting abnormalities in adult behaviors, and result in robust decreases in the expression of a major serotonin synthetic enzyme (tryptophan hydroxylase) along the raphe midline. In the present investigation, we injected rat pups with citalopram (CTM: 5 mg/kg, 10 mg/kg, and 20 mg/kg) from postnatal Days 8–21, and examined serotonin transporter (SERT) labeling in the hippocampus, ventrobasal thalamic complex, and caudate‐putamen when the subjects reached adulthood. Our data support the idea, that forebrain targets in receipt of innervation from the raphe midline are particularly vulnerable to the effects of CTM. SERT‐immunoreactive fiber density was preferentially decreased throughout all sectors of the hippocampal formation, whereas the subcortical structures, each supplied by more lateral and rostral aspects of the raphe complex, respectively, were not significantly affected. Reductions in SERT staining were also found to be dose‐dependent. These findings suggest that SSRIs may not only interfere with the establishment of chemically balanced circuits in the neonate but also impose selective impairment on higher cortical function and cognitive processes via more circumscribed (i.e., regionally specific) deficits in 5‐HT action. Anat Rec, 2010.Keywords
This publication has 48 references indexed in Scilit:
- Neonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin CircuitryNeuropsychopharmacology, 2005
- Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult MiceScience, 2004
- Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during developmentDevelopmental Brain Research, 2004
- Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn NeurobehaviorPEDIATRICS, 2004
- Placental Passage of Antidepressant MedicationsAmerican Journal of Psychiatry, 2003
- Neuropathology of Mice Carrying Mutant APPswe and/or PS1M146L Transgenes: Alterations in the p75NTR Cholinergic Basal Forebrain Septohippocampal PathwayExperimental Neurology, 2001
- Risk-Benefit Decision Making for Treatment of Depression During PregnancyAmerican Journal of Psychiatry, 2000
- Projections of the median raphe nucleus in the ratJournal of Comparative Neurology, 1999
- Serotonergic Neuronal SystemsJournal of Clinical Psychopharmacology, 1987
- Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopramEuropean Journal of Clinical Pharmacology, 1985